Germline BRCA pathogenic variants in patients with ovarian cancer and post-poly (ADP-ribose) polymerase inhibitor myeloid neoplasms

Authors: Valenza, C., Mongillo, M., Gigli, F., Trapani, D., Katrini, J., Nicolò, E., Boldrini, L., Boscolo Bielo, L., Castellano, G., Guidi, L., Pellizzari, G., Derio, S., Lapresa, M., Parma, G., Derenzini, E., Curigliano, G., Colombo, N.

Source: In ESMO Open September 2024 9(9)

Unfavorable carcinoma of unknown primary with a gastrointestinal profile: a retrospective study

Authors: Guidi, L. ^{1, 2, †}, Valenza, C. ^{1, 2, †}, Battaiotto, E. ^{1, 2}, Trapani, D. ^{1, 2}, Ghioni, M.C. ³, Crimini, E. ^{1, 2}, Boscolo Bielo, L. ^{1, 2}, Venetis, K. ³, Belli, C. ¹, Bottiglieri, L. ³, Gervaso, L. ⁴, Cella, C.A. ⁴, Ciardiello, D. ⁴, Spada, F. ⁴, Benini, L. ⁴, Adorisio, R. ³, Mane, E. ³, Fazio, N. ⁴, Guerini Rocco, E. ³, Curigliano, G. ^{1, 2, ∗}, Zampino, M.G. ^{4, †}

Source: In ESMO Open August 2024 9(8)

Interstitial lung disease in patients enrolled in early-phase clinical trials: the ILDE study

Authors: Trapani, D. ^{1, 2, †}, Scalia, R. ^{1, 2, 3, †}, Giordano, E. ^{1, 2}, Castellano, G. ², Doi, G. ⁴, Gaeta, A. ⁴, Pellizzari, G. ^{1, 2}, Carnevale Schianca, A. ^{1, 2}, Katrini, J. ^{1, 2}, D’Ambrosio, S. ^{1, 2}, Santoro, C. ^{1, 2}, Guidi, L. ^{1, 2}, Valenza, C. ^{1, 2}, Belli, C. ², Gandini, S. ⁴, Russo, A. ⁴, Curigliano, G. ^{1, 2, ∗}

Source: In ESMO Open August 2024 9(8)

Role of the microbiome in the development and treatment of gastric cancer: an overview of the biological and clinical landscape

Authors: Cella, C.A., Ciardiello, D., Gervaso, L., van Laarhoven, H., Nezi, L., Catozzi, C., Lordick, F., Smyth, E., de Pascale, S., Benini, L., Valenza, C., Guidi, L., Fumagalli Romario, U., Fazio, N.

Source: In ESMO Gastrointestinal Oncology June 2024 4

Promising targetable biomarkers in pancreatic neuroendocrine tumours

Authors: Borghesani, M., Gervaso, L., Cella, C.A., Benini, L., Ciardiello, D., Algeri, L., Ferrero, A., Valenza, C., Guidi, L., Zampino, MG., Spada, F., Fazio, N.

Source: Expert review of endocrinology & metabolism. 18(5):387-398

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100194131316.0x000001&indx=1&recIds=ETOCvdc_100194131316.0x000001

Elacestrant in ESR1-mutant, endocrine-responsive metastatic breast cancer: should health authorities consider post hoc data to inform priority access?

Authors: Valenza, C., Trapani, D., Bidard, F.-C., Gligorov, J., Cortés, J., Turner, N., Dalenc, F., Penault-Llorca, F., Freyer, G., Arnedos, M., Villanueva, C., Loibl, S., Pistilli, B., Curigliano, G.

Source: In ESMO Open September 2024 9(9)

101P Primary malignant phyllodes tumors of the breast: A retrospective analysis from a referral center

Authors: Valenza, C., De Pas, T.M., Gaeta, A., Castellano, G., Santoro, C., Battaiotto, E., Burroni, M., Chiappini, G., Vivanet, G., Trapani, D., Coppola, S., Conforti, F., Mattar, D., Gandini, S., Veronesi, P., Pennacchioli, E., Curigliano, G.

Source: In ESMO Open March 2024 9 Supplement 2

225P Platinum-based chemotherapy and PARP Inhibitors for BRCA mutated metastatic breast cancer (LATER-BC): Retrospective multicentre analysis of post-progression treatments

Authors: Valenza, C., Trapani, D., Sposetti, C., Bielo, L. Boscolo, Marra, A., Giarratano, T., Cortesi, L., Moscetti, L., Pistelli, M., Berardi, R., Zambelli, A., Guarneri, V., Vernieri, C., Curigliano, G.

Source: In ESMO Open May 2023 8(1) Supplement 4

83P The Immune-related adverse event (IRAE) Likelihood Score (ILS) identifies “pure” IRAEs strongly associated with outcome in a phase I-II trial population

Authors: Mazzarella, L., Nicolo, E., Esposito, A., Crimini, E., Tini, G., Uliano, J., Corti, C., Trillo Aliaga, P.M., Valenza, C., Repetto, M., Antonarelli, G., Minchella, I., Belli, C., Locatelli, M.A., Criscitiello, C., Curigliano, G.

Source: In Immuno-Oncology and Technology December 2022 16 Supplement 1

Effectiveness of an occupational therapy intervention in reducing emotional distress in informal caregivers of hip fracture patients: a randomized controlled trial

Authors: Martin-Martin, L.M., Valenza-Demet, G., Ariza-Vega, P., Valenza, C., Castellote-Caballero, Y., Jimenez-Moleon, J.J.

Source: CLINICAL REHABILITATION. 28(8):772-783

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN356765344&indx=1&recIds=ETOCRN356765344

The Modern History of Visual Thinking: Graphic Facilitation and Worldview

Authors: Valenza, C., Adkins, J.

Source: INTERACTIONS -NEW YORK-. 16(4):38-43

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN254753736&indx=1&recIds=ETOCRN254753736

2293P Protumoral role of neutrophils and neutrophils extracellular traps (NETS) in non-metastatic gastroesophageal and rectal cancers

Authors: Catozzi, C., Gervaso, L., Benini, L., Ciardiello, D., Zampino, M.G., Spada, F., Borghesani, M., Valenza, C., Algeri, L., Guidi, L., Pellizzari, G., Fazio, N., Nezi, L., Cella, C.A.

Source: In Annals of Oncology October 2023 34 Supplement 2:S1174-S1174

1942P Non-metastatic malignant phyllodes tumors of the breast (B-MPT): A retrospective analysis from a referral center

Authors: Valenza, C., De Pas, T.M., Castellano, G., Santoro, C., Corona, A., Chiappini, G., Vivanet, G., Trapani, D., Conforti, F., Coppola, S., Mattar, D., Veronesi, P., Pennacchioli, E., Curigliano, G.

Source: In Annals of Oncology October 2023 34 Supplement 2:S1042-S1043

2148P Venous thromboembolism (VTE) in patients with advanced high grade ovarian carcinoma (aHGOC) receiving PARP inhibitors

Authors: Gervaso, L., Valenza, C., Mongillo, M., Boldrini, L., Bielo, L. Boscolo, Castellano, G., Guidi, L., Katrini, J., Nicolo, E., Pellizzari, G., Trapani, D., Cella, C.A., Lorenzetti, I.T., Derio, S., La Presa, M.T., Parma, G., Fazio, N., Curigliano, G., Khorana, A.A., Colombo, N.

Source: In Annals of Oncology October 2023 34 Supplement 2:S1118-S1119

2041P The prevalence of hematologic adverse events (HAEs) and myelodysplastic syndrome/acute myeloid leukemia (MDS/AML) in patients (pts) with advanced high grade ovarian carcinoma (aHGOC) receiving PARP inhibitor (PARPi), with or without a germline BRCA pathogenic variant

Authors: Valenza, C., Nicolo, E., Mongillo, M., Trapani, D., Gigli, F., Boldrini, L., Bielo, L. Boscolo, Castellano, G., Guidi, L., Katrini, J., Pellizzari, G., Villa, J., Lorenzetti, I.T., Derio, S., La Presa, M.T., Parma, G., Curigliano, G., Colombo, N.

Source: In Annals of Oncology October 2023 34 Supplement 2:S1082-S1082

The Amyloid Precursor Protein Interacts with G~o Heterotrimeric Protein within a Cell Compartment Specialized in Signal Transduction

Authors: Brouillet, E., Trembleau, A., Galanaud, D., Volovitch, M., Bouillot, C., Valenza, C., Prochiantz, A., Allinquant, B.

Source: JOURNAL OF NEUROSCIENCE. 19(5):1717-1727

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN057308126&indx=1&recIds=ETOCRN057308126

P-96 Circulating tumor-derived DNA (ctDNA) clearance in patients with locally advanced rectal cancer treated with multimodal treatment

Authors: Gervaso, L., Ciardiello, D., Ascione, L., Boldrini, L., Guidi, L., Valenza, C., Gregato, G., Funicelli, L., Bottiglieri, L., De Roberto, G., Petz, W., Borin, S., Romario, U. Fumagalli, Gerardi, M., Bertolini, F., Curigliano, G., Fazio, N., Zampino, M.

Source: In Annals of Oncology June 2023 34 Supplement 1:S48-S48

42P Comparative real-world analysis of pembrolizumab plus chemo vs platinum-doublet alone in metastatic non-squamous NSCLC with PD-L1 low

Authors: Attili, I., Valenza, C., Santoro, C., Antonarelli, G., Trillo Aliaga, P., Del Signore, E., Catania, C., Spitaleri, G., Passaro, A., de Marinis, F.

Source: In Annals of Oncology April 2022 33 Supplement 2:S51-S51

79P Immune-related adverse events are correlated with significantly improved outcome in a phase I trial population exposed to combination immunotherapy

Authors: Mazzarella, L., Giugliano, F., Crimini, E., Uliano, J., Corti, C., D'Amico, P., Trillo Aliaga, P., Valenza, C., Repetto, M., Nicolo, E., Antonarelli, G., Ascione, L., Vivanet, G., Berton Giachetti, P.P.M., Belli, C., Criscitiello, C., Esposito, A., Locatelli, M.A., Minchella, I., Curigliano, G.

Source: In Annals of Oncology December 2021 32 Supplement 7:S1406-S1406

Defined Glycosaminoglycan Motifs Have Opposite Effects on Neuronal Polarity in Vitro

Authors: Lafont, F., Prochiantz, A., Valenza, C., Petitou, M.

Source: DEVELOPMENTAL BIOLOGY -ACADEMIC PRESS-. 165(2):453-453

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCEN021625036&indx=1&recIds=ETOCEN021625036